Case Study: Second Genome accelerates secure, petabyte-scale drug discovery with Provectus

Second Genome accelerates petabyte-scale drug discovery with Provectus

Second Genome, a biotechnology company specializing in microbiome-based drug discovery, faced the challenge of scaling its proprietary research platform to meet the strict security and compliance requirements of premium pharmaceutical partners. To strengthen its market position and enable petabyte-scale research, the company partnered with Provectus to redesign its data infrastructure and build new machine learning capabilities.

Provectus redesigned and built a secure, cloud-native data platform on AWS for Second Genome, implementing automated data pipelines, robust security measures like encryption and multi-factor authentication, and ML infrastructure for biomarker contextualization. The solution resulted in a fully compliant environment capable of supporting industrial-scale, petabyte-sized drug research projects, enabling Second Genome to securely onboard new pharma partners and accelerate its biomarker and drug discovery work.

Second Genome